New Delhi:The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has issued an addendum to its earlier price fixation orders for scheduled formulations of Ringer Lactate (non-glass with special features). The addendum, dated August 29, 2025, modifies NPPA’s earlier orders S.O. 1474(E) dated March 27, 2025, and S.O. 2998(E) dated July 4, 2025, by adding three manufacturers under Table B for ceiling price applicability. The notification states: “Sl. No. 23, 24 and 25 shall be added in Table ‘B’ as below:” Name of Manufacturer Product/ Brand Name M/s BML Parenteral Drugs (note e2 below) Euro Head Cap M/s Hindustan Polyfab (note e3 below) Euro Head /LDPE Bottles M/s Pharma Implex Laboratories Pvt. Ltd. (note e4 below) Euro Cap/Head Bottles Further clarifications have been issued regarding applicable ceiling prices for these manufacturers: For M/s BML Parenteral Drugs, only formulations at Sl. No. 2 and 3 of Table A are applicable. For M/s Hindustan Polyfab, only the formulation at Sl. No. 3 of Table A is applicable. For M/s Pharma Implex Laboratories Pvt. Ltd., only formulations at Sl. No. 3 and 4 of Table A are applicable. The addendum has been published in the Gazette of India as notification S.O. 3978(E), with Dy. Director Mahaveer Saini signing the order. To view the official notification, click on the link below: